Decreased brainstem and putamen sert binding potential in depressed suicide attempters using [11C]-zient pet imaging

Depression and Anxiety

Volumn 30, Issue 10, 2013, Pages 902-907

  Nye, Jonathon A ^a   Purselle, David ^a   Plisson, Christophe ^a   Voll, Ronald J ^a   Stehouwer, Jeffrey S ^a   Votaw, John R ^a   Kilts, Clinton D ^a   Goodman, Mark M ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

biological markers; brain imaging neuroimaging; depression; measurement psychometrics; suicide self harm

Indexed keywords

RADIOPHARMACEUTICAL AGENT; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; ZIENT C 11;

ADULT; ARTICLE; BINDING AFFINITY; BRAIN REGION; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FOREBRAIN; HUMAN; MAJOR DEPRESSION; MALE; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PONS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SEROTONINERGIC SYSTEM; SUICIDE ATTEMPT;

BIOLOGICAL MARKERS; BRAIN IMAGING/NEUROIMAGING; DEPRESSION; MEASUREMENT/PSYCHOMETRICS; SUICIDE/SELF-HARM;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BRAIN MAPPING; BRAIN STEM; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NORTROPANES; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84885624613     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22049     Document Type: Article

References (45)

1. Mann JJ, Huang YY, Underwood MD, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000; 57 (8): 729-738.
2. Gillespie CF, Garlow SJ, Binder EB, Schatzberg AF, Nemeroff CB,. Neurobiology of Mood Disorders. 4th ed. Washington, DC: American Psychiatric Publishing; 2009.
3. Gos T, Krell D, Brisch R, et al. Demonstration of decreased activity of dorsal raphe nucleus neurons in depressed suicidal patients by the AgNOR staining method. J Affect Disord 2008; 111 (2-3): 251-260.
4. Underwood MD, Khaibulina AA, Ellis SP, et al. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol Psychiatry 1999; 46 (4): 473-483.
5. Cortes R, Soriano E, Pazos A, Probst A, Palacios JM,. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine. Neuroscience 1988; 27 (2): 473-496.
6. Laruelle M, Vanisberg MA, Maloteaux JM,. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites. Biol Psychiatry 1988; 24 (3): 299-309.
7. Arango V, Underwood MD, Boldrini M, et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001; 25 (6): 892-903.
8. Little KY, McLauglin DP, Ranc J, et al. Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide. Biol Psychiatry 1997; 41 (12): 1156-1164.
9. Bligh-Glover W, Kolli TN, Shapiro-Kulnane L, et al. The serotonin transporter in the midbrain of suicide victims with major depression. Biol Psychiatry 2000; 47 (12): 1015-1024.
10. Ikoma Y, Suhara T, Toyama H, et al. Quantitative analysis for estimating binding potential of the brain serotonin transporter with [11 C]McN5652. J Cereb Blood Flow Metab 2002; 22 (4): 490-501.
11. Frankle WG, Slifstein M, Gunn RN, et al. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. J Nucl Med 2006; 47 (5): 815-826.
12. Frankle WG, Huang Y, Hwang D-R, et al. Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. J Nucl Med 2004; 45 (4): 682-694.
13. Bah J, Lindstrom M, Westberg L, et al. Serotonin transporter gene polymorphisms: effect on serotonin transporter availability in the brain of suicide attempters. Psychiatry Res 2008; 162 (3): 221-229.
14. Parsey RV, Hastings RS, Oquendo MA, et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 2006; 163 (1): 52-58.
15. Lindstrom MB, Ryding E, Bosson P, Ahnlide JA, Rosen I, Traskman-Bendz L,. Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. Eur Neuropsychopharmacol 2004; 14 (4): 295-300.
16. Cannon DM, Ichise M, Rollis D, et al. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biol Psychiatry 2007; 62 (8): 870-877.
17. Ichimiya T, Suhara T, Sudo Y, et al. Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652. Biol Psychiatry 2002; 51 (9): 715-722.
18. Meyer JH, Houle S, Sagrati S, et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 2004; 61 (12): 1271-1279.
19. Huang Y, Zheng MQ, Gerdes JM,. Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination? Curr Top Med Chem 2010; 10 (15): 1499-1526.
20. First MB, Donovan S, Frances A,. Nosology of chronic mood disorders. Psychiatr Clin North Am 1996; 19 (1): 29-39.
21. Plisson C, Jarkas N, McConathy J, et al. Evaluation of carbon-11-labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-iodoethenyl)phenyl]nortropane as a potential radioligand for imaging the serotonin transporter by PET. J Med Chem 2006; 49 (3): 942-946.
22. de Jong HW, van Velden FH, Kloet RW, Buijs FL, Boellaard R, Lammertsma AA,. Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner. Phys Med Biol 2007; 52 (5): 1505-1526.
23. Hong IK, Chung ST, Kim HK, Kim YB, Son YD, Cho ZH,. Ultra fast symmetry and SIMD-based projection-backprojection (SSP) algorithm for 3-D PET image reconstruction. IEEE Trans Med Imaging 2007; 26 (6): 789-803.
24. Talairach J, Tournoux P,. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging. Stuttgart; New York, NY: G. Thieme; Thieme Medical Publishers; 1988.
25. Kish SJ, Furukawa Y, Chang LJ, et al. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl Med Biol 2005; 32 (2): 123-128.
26. Lammertsma AA, Hume SP,. Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4 (3): 153-158.
27. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ,. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984; 15 (3): 217-227.
28. Cannon DM, Ichise M, Fromm SJ, et al. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry 2006; 60 (3): 207-217.
29. Klimek V, Roberson G, Stockmeier CA, Ordway GA,. Serotonin transporter and MAO-B levels in monoamine nuclei of the human brainstem are normal in major depression. J Psychiatr Res 2003; 37 (5): 387-397.
30. Bielau H, Mawrin C, Krell D, et al. Differences in activation of the dorsal raphe nucleus depending on performance of suicide. Brain Res 2005; 1039 (1-2): 43-52.
31. Lin P-Y, Tsai G,. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol Psychiatry 2004; 55 (10): 1023-1030.
32. Gos T, Gunther K, Bielau H, et al. Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil. J Affect Disord 2009; 113 (1-2): 45-55.
33. Li D, He L,. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry 2007; 12 (1): 47-54.
34. Ryding E, Ahnlide JA, Lindstrom M, Rosen I, Traskman-Bendz L,. Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Res 2006; 148 (2-3): 195-203.
35. Jovanovic H, Lundberg J, Karlsson P, et al. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage 2008; 39 (3): 1408-1419.
36. Ruhé H, Booij J, Reitsma J, Schene A,. Serotonin transporter binding with [123I]β-CIT SPECT in major depressive disorder versus controls: effect of season and gender. Eur J Nucl Med Mol Imaging 2009; 36 (5): 841-849.
37. Kalbitzer J, Erritzoe D, Holst KK, et al. Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes. Biol Psychiatry 2010; 67 (11): 1033-1039.
38. Praschak-Rieder N, Willeit M, Wilson AA, Houle S, Meyer JH,. Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry 2008; 65 (9): 1072-1078.
39. Carson RE, Daube-Witherspoon ME, Herscovitch P,. Quantitative Functional Brain Imaging with Positron Emission Tomography. San Diego, CA: Academic Press; 1998.
40. PET Phantom Instructions for Evaluation of PET Image Quality/ACR Nuclear Medicine Accreditation Program. Reston, VA: American College of Radiology.
41. Kung M-P, Kung HF,. Mass effect of injected dose in small rodent imaging by SPECT and PET. Nucl Med Biol 2005; 32 (7): 673-678.
42. Jagoda EM, Vaquero JJ, Seidel J, Green MV, Eckelman WC,. Experiment assessment of mass effects in the rat: implications for small animal PET imaging. Nucl Med Biol 2004; 31 (6): 771-779.
43. Ginovart N, Wilson AA, Meyer JH, Hussey D, Houle S,. Positron emission tomography quantification of [lsqb]11C[rsqb]-DASB binding to the human serotonin transporter[colon] modeling strategies. J Cereb Blood Flow Metab 2001; 21 (11): 1342-1353.
44. Parsey RV, Kegeles LS, Hwang DR, et al. In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652. J Nucl Med 2000; 41 (9): 1465-1477.
45. Lundberg J, Odano I, Olsson H, Halldin C, Farde L,. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. J Nucl Med 2005; 46 (9): 1505-1515.